Generics Joining The 12-Month Stability Data Club, But “When?” Is Big Question
Executive Summary
Generic drug sponsors will need to submit six-month and 12-month stability data for their ANDAs under draft guidance being developed by the Office of Generic Drugs.
You may also be interested in...
ANDAs To Include Six Months Of Stability Test Data Under FDA Draft Guidance
The agency advises sponsors to follow the stability testing recommendations in the International Conference on Harmonization guidances; three companies submit comments seeking clarification from FDA.
ANDAs To Include Six Months Of Stability Test Data Under FDA Draft Guidance
The agency advises sponsors to follow the stability testing recommendations in the International Conference on Harmonization guidances; FDA had considered requiring 12 months of data.
FDA’s Guidance Document To-Do List Grows
Since releasing its annual guidance agenda in December, FDA has added a number of guidances to its development agenda.